Compare BMRN & CIFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BMRN | CIFR |
|---|---|---|
| Founded | 1996 | 2021 |
| Country | United States | United States |
| Employees | N/A | 66 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 11.3B |
| IPO Year | 1999 | N/A |
| Metric | BMRN | CIFR |
|---|---|---|
| Price | $58.97 | $20.14 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 11 |
| Target Price | ★ $88.22 | $24.91 |
| AVG Volume (30 Days) | 1.9M | ★ 22.5M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $1,313,646,000.00 | N/A |
| Revenue This Year | $15.02 | $12.29 |
| Revenue Next Year | $12.23 | $240.53 |
| P/E Ratio | $109.20 | ★ N/A |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $49.26 | $4.55 |
| 52 Week High | $66.28 | $30.14 |
| Indicator | BMRN | CIFR |
|---|---|---|
| Relative Strength Index (RSI) | 61.76 | 37.33 |
| Support Level | $53.32 | $13.20 |
| Resistance Level | $61.92 | $21.88 |
| Average True Range (ATR) | 1.49 | 2.50 |
| MACD | 0.19 | -0.77 |
| Stochastic Oscillator | 85.48 | 7.02 |
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Cipher Digital Inc is focused on high-performance computing (HPC) data center development and operations. It is engaged in developing and operating data centers designed for HPC workloads. Its operations include managing power assets and capital allocation in response to market conditions and demand for AI-related computing capacity.